Evidence map›Paper›PMID 42682451›Full record

ArticleFrontiers in immunology2026

Dynamic integration of CXCL8 or CCL20 signaling with IL-15 or IL-32α reprograms human T-cell functional plasticity.

Messias de Oliveira Pacheco, Larissa Figueiredo Alves Diniz, Gabriela Alves Theodoro, Sabrina do Nascimento, Matheus Farinaro Vesco, Helder Nakaya, Luiz Vicente Rizzo, Fernanda Agostini Rocha, Patrícia Severino, Luciana Cavalheiro Marti

Abstract read
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Messias de Oliveira PachecoFaculdade Israelita de Ciências da Saúde Albert Einstein, Hospital Israelita Albert Einstein - Department of Experimental Research, São Paulo, Brazil.
Larissa Figueiredo Alves DinizFaculdade Israelita de Ciências da Saúde Albert Einstein, Hospital Israelita Albert Einstein - Department of Experimental Research, São Paulo, Brazil.
Gabriela Alves TheodoroFaculdade Israelita de Ciências da Saúde Albert Einstein, Hospital Israelita Albert Einstein - Medical School, São Paulo, Brazil.
Sabrina do NascimentoFaculdade Israelita de Ciências da Saúde Albert Einstein, Hospital Israelita Albert Einstein - Department of Experimental Research, São Paulo, Brazil.
Matheus Farinaro VescoFaculdade Israelita de Ciências da Saúde Albert Einstein, Hospital Israelita Albert Einstein - Department of Experimental Research, São Paulo, Brazil.
Helder NakayaFaculdade Israelita de Ciências da Saúde Albert Einstein, Hospital Israelita Albert Einstein - Department of Experimental Research, São Paulo, Brazil.
Luiz Vicente RizzoFaculdade Israelita de Ciências da Saúde Albert Einstein, Hospital Israelita Albert Einstein - Department of Experimental Research, São Paulo, Brazil.
Fernanda Agostini RochaFaculdade Israelita de Ciências da Saúde Albert Einstein, Hospital Israelita Albert Einstein - Department of Experimental Research, São Paulo, Brazil.
Patrícia SeverinoFaculdade Israelita de Ciências da Saúde Albert Einstein, Hospital Israelita Albert Einstein - Department of Experimental Research, São Paulo, Brazil.
Luciana Cavalheiro MartiFaculdade Israelita de Ciências da Saúde Albert Einstein, Hospital Israelita Albert Einstein - Department of Experimental Research, São Paulo, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Tissue-derived chemokines can direct immune cell migration by engaging specific receptors, thereby controlling the localization and trafficking of immune cells within tissues. However, how chemokines modulate cytokines-driven transcriptional programs in T cells remain unclear. This study investigated how CXCL8 and CCL20 influence human T cell responses to IL-15 and IL-32α. Methods: Peripheral blood T cells from health donors were evaluated for the expression and functional activity of the chemokine receptors CCR6, CXCR1, and CXCR2. Chemokine induced migration was assessed using Results: Peripheral blood T cells expressed CCR6, CXCR1, and CXCR2, which were downregulated during Discussion: These findings demonstrated that chemokine and cytokine signals are integrated in a context-dependent manner to regulate T cells migration, activation, survival and proliferation. Rather than acting solely as chemoattractant, CCL20 and CXCL8 can reshape cytokine-driven transcriptional profile programs, revealing additional regulatory layer that may contribute to T cell functional plasticity within inflammatory and tumor microenvironment.

Indexed as

Chemokine CCL20Interleukin-15Interleukin-8InterleukinsSignal TransductionT-LymphocytesCell MovementCells, CulturedGene Expression ProfilingHumansCCL20 protein, humanChemokine CCL20CXCL8 protein, humanIL15 protein, humanInterleukin-15Interleukin-8InterleukinsCCL20cell migration and inflammationchemokinesCXCL8cytokinesIL-15IL-32

Identifiers

PMID42682451
PMCPMC13529521

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.